» Articles » PMID: 25952471

A Centralized Cardiovascular Risk Service to Improve Guideline Adherence in Private Primary Care Offices

Abstract

Background: Many large health systems now employ clinical pharmacists in team-based care to assist patients and physicians with management of cardiovascular (CV) diseases. However, small private offices often lack the resources to hire a clinical pharmacist for their office. The purpose of this study is to evaluate whether a centralized, web-based CV risk service (CVRS) managed by clinical pharmacists will improve guideline adherence in primary care medical offices in rural and small communities.

Methods: This study is a cluster randomized prospective trial in 12 primary care offices. Medical offices were randomized to either the CVRS intervention or usual care. The intervention will last for 12 months and all subjects will have research visits at baseline and 12 months. Primary outcomes will include adherence to treatment guidelines and control of key CV risk factors. Data will also be abstracted from the medical record at 30 months to determine if the intervention effect is sustained after it is discontinued.

Conclusions: This study will enroll subjects through 2015 and results will be available in 2018. This study will provide information on whether a distant, centralized CV risk service can improve guideline adherence in medical offices that lack the resources to employ clinical pharmacists.

Citing Articles

Development of a centralized, remote clinical pharmacy service to enhance primary care.

Finkelstein R, Parker C, Levy B, Carter B, Kennelty K Pharm Pract (Granada). 2021; 19(1):2348.

PMID: 33777264 PMC: 7979315. DOI: 10.18549/PharmPract.2021.1.2348.


Dissemination of a telehealth cardiovascular risk service: The CVRS live protocol.

Kennelty K, Engblom N, Carter B, Hollingworth L, Levy B, Finkelstein R Contemp Clin Trials. 2021; 102:106282.

PMID: 33444781 PMC: 8627195. DOI: 10.1016/j.cct.2021.106282.


A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Polgreen L, Carter B, Polgreen P, Snyder P, Sewell D, Bayman E Contemp Clin Trials. 2020; 98:106169.

PMID: 33038500 PMC: 7686143. DOI: 10.1016/j.cct.2020.106169.


Self-identified barriers to rural mental health services in Iowa by older adults with multiple comorbidities: qualitative interview study.

Pass L, Kennelty K, Carter B BMJ Open. 2019; 9(11):e029976.

PMID: 31685497 PMC: 6858190. DOI: 10.1136/bmjopen-2019-029976.


Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.

Carter B, Levy B, Gryzlak B, Xu Y, Chrischilles E, Dawson J Circ Cardiovasc Qual Outcomes. 2018; 11(6):e004188.

PMID: 29884657 PMC: 5996776. DOI: 10.1161/CIRCOUTCOMES.117.004188.


References
1.
Carter B, Clarke W, Ardery G, Weber C, James P, Vander Weg M . A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2010; 3(4):418-23. PMC: 2931811. DOI: 10.1161/CIRCOUTCOMES.109.908038. View

2.
Goldstein L, Adams R, Alberts M, Appel L, Brass L, Bushnell C . Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing.... Stroke. 2006; 37(6):1583-633. DOI: 10.1161/01.STR.0000223048.70103.F1. View

3.
Cabana M, Rand C, Powe N, Wu A, Wilson M, Abboud P . Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282(15):1458-65. DOI: 10.1001/jama.282.15.1458. View

4.
Ellis S, Carter B, Malone D, Billups S, Okano G, Valuck R . Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000; 20(12):1508-16. DOI: 10.1592/phco.20.19.1508.34852. View

5.
Williams M, Fleg J, Ades P, Chaitman B, Miller N, Mohiuddin S . Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac.... Circulation. 2002; 105(14):1735-43. DOI: 10.1161/01.cir.0000013074.73995.6c. View